| Nome |
# |
|
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease, file e3835322-92f2-15e8-e053-a505fe0a3de9
|
449
|
|
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease, file e3835321-a0dd-15e8-e053-a505fe0a3de9
|
328
|
|
Gelatin tannate for acute childhood gastroenteritis: a randomized, single-blind controlled trial, file e3835323-0099-15e8-e053-a505fe0a3de9
|
272
|
|
Corrigendum to: Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicenter study, file e383532c-1b26-15e8-e053-a505fe0a3de9
|
206
|
|
Predicting outcomes in pediatric ulcerative colitis for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease–ahead program, file e383532c-0805-15e8-e053-a505fe0a3de9
|
167
|
|
Predicting outcomes in pediatric Crohn's disease for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease–ahead program, file e383532c-17d1-15e8-e053-a505fe0a3de9
|
134
|
|
Intestinal inflammation alters the expression of hepatic bile acid receptors causing liver impairment, file e3835326-4aa3-15e8-e053-a505fe0a3de9
|
131
|
|
Obese patients with a binge eating disorder have an unfavorable metabolic and inflammatory profile, file e3835323-231a-15e8-e053-a505fe0a3de9
|
99
|
|
Transcription factor ZNF281: a novel player in intestinal inflammation and fibrosis, file e3835322-1f64-15e8-e053-a505fe0a3de9
|
97
|
|
Efficacy of adalimumab as second-line therapy in a pediatric cohort of crohn’s disease patients who failed infliximab therapy: the Italian society of pediatric gastroenterology, hepatology, and nutrition experience, file e3835321-ef86-15e8-e053-a505fe0a3de9
|
70
|
|
Atopic manifestations in children born preterm: a long-term observational study, file e383532c-d19b-15e8-e053-a505fe0a3de9
|
54
|
|
Long-term effects on growth of an energy-enhanced parenteral nutrition in preterm newborn: a quasi-experimental study, file e3835327-bc6f-15e8-e053-a505fe0a3de9
|
47
|
|
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course, file e383532c-1b28-15e8-e053-a505fe0a3de9
|
41
|
|
Advances in the medical management of paediatric IBD, file e3835313-ed39-15e8-e053-a505fe0a3de9
|
39
|
|
Ultrasonography of the Colon in Pediatric Ulcerative Colitis: A Prospective, Blind, Comparative Study with Colonoscopy, file e3835312-6357-15e8-e053-a505fe0a3de9
|
30
|
|
Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease, file e3835312-4697-15e8-e053-a505fe0a3de9
|
22
|
|
Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn’s Disease, file 1666debd-a87f-432e-8a40-050af5083df9
|
21
|
|
Premature Subclinical Atherosclerosis in Pediatric Inflammatory Bowel Disease, file e3835312-1c9b-15e8-e053-a505fe0a3de9
|
17
|
|
Endoplasmic reticulum stress and unfolded protein response are
involved in paediatric inflammatory bowel disease, file e3835312-4694-15e8-e053-a505fe0a3de9
|
15
|
|
A promising medium-term follow-up of pediatric sclerosing cholangitis. Mild phenotype or early diagnosis, file e383531b-6332-15e8-e053-a505fe0a3de9
|
14
|
|
International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study, file e383532c-1b27-15e8-e053-a505fe0a3de9
|
13
|
|
Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease, file e3835312-55fe-15e8-e053-a505fe0a3de9
|
11
|
|
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease, file e3835313-ed2f-15e8-e053-a505fe0a3de9
|
8
|
|
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features, file e383531b-0bea-15e8-e053-a505fe0a3de9
|
8
|
|
A Prospective 52-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn's Disease as Detected by Colon Capsule Endoscopy, file e3835317-b034-15e8-e053-a505fe0a3de9
|
7
|
|
Clinical Trials (Clinician Perspective), file e3835311-fa63-15e8-e053-a505fe0a3de9
|
6
|
|
Human herpes virus-6 chromosomal integration misled the management of Crohn's disease., file e3835312-11bb-15e8-e053-a505fe0a3de9
|
6
|
|
Mapping Histologic Patchiness of Celiac Disease by Push Enteroscopy, file e3835312-1f06-15e8-e053-a505fe0a3de9
|
6
|
|
Drug Development: The Use of Unlicensed/Off-label Medicines in Pediatrics, file e3835312-449f-15e8-e053-a505fe0a3de9
|
6
|
|
A prospective 52-week mucosal healing and deep remission assessment of small bowel and colonic Crohn’s disease as detected by colon capsule endoscopy, file e3835317-a2c0-15e8-e053-a505fe0a3de9
|
6
|
|
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease, file e383531a-3375-15e8-e053-a505fe0a3de9
|
6
|
|
Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis, file dffcbd34-62e7-4331-a15d-5fe14b71e122
|
5
|
|
Role of Methotrexate in Pediatric Ulcerative Colitis, file e3835312-1f9a-15e8-e053-a505fe0a3de9
|
5
|
|
Predicting the durability of biological therapy in pediatric Crohn's disease: do the immunomodulators matter?, file e3835312-e300-15e8-e053-a505fe0a3de9
|
5
|
|
705 A Prospective 24-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn Disease as Detected by Colon Capsule Endoscopy, file e3835317-e379-15e8-e053-a505fe0a3de9
|
5
|
|
CEACAM6: A Possible Role in Pediatric Crohn's Disease?, file e3835311-f0f7-15e8-e053-a505fe0a3de9
|
4
|
|
Gut microbiota and pediatric disease, file e3835312-03b1-15e8-e053-a505fe0a3de9
|
4
|
|
Argon plasma coagulator in a 2-month-old child with tracheoesophageal fistula, file e3835312-06d3-15e8-e053-a505fe0a3de9
|
4
|
|
Outcome of Biological Therapy in Pediatric Inflammatory Bowel Disease at a Single Tertiary Center, file e3835312-1c99-15e8-e053-a505fe0a3de9
|
4
|
|
Altered Coagulation in Pediatric Inflammatory Bowel Disease: Role on Inherited and Acquired Risk Factors, file e3835312-1c9a-15e8-e053-a505fe0a3de9
|
4
|
|
Early Versus Late Immunomodulatory Therapy in Pediatric CD: A Prospective Observational Study in a Tertiary Referral Center, file e3835312-1f7e-15e8-e053-a505fe0a3de9
|
4
|
|
Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: A randomized, double-blind, placebo controlled trial, file e3835312-2fad-15e8-e053-a505fe0a3de9
|
4
|
|
First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease, file e3835319-b800-15e8-e053-a505fe0a3de9
|
4
|
|
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release, file e3835312-35e1-15e8-e053-a505fe0a3de9
|
3
|
|
Natural history of pancreatic involvement in paediatric inflammatory bowel disease, file e3835320-6b45-15e8-e053-a505fe0a3de9
|
3
|
|
Prospective evaluation of the achievement of mucosal healing with anti-TNF-α therapy in a paediatric Crohn's disease cohort, file e3835321-7fbb-15e8-e053-a505fe0a3de9
|
3
|
|
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time, file e3835328-1460-15e8-e053-a505fe0a3de9
|
3
|
|
A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years, file f53a4ef6-67ce-484a-bfdd-0a2e99ee2e6f
|
3
|
|
Intestinal lymphoid nodular hyperplasioa in children. the relationship to food allergy, file e3835313-17aa-15e8-e053-a505fe0a3de9
|
2
|
|
Predictors of long-term clinical and endoscopic remission in children with crohn disease treated with infliximab, file e3835321-fb7a-15e8-e053-a505fe0a3de9
|
2
|
|
Capsule endoscopy followed by single balloon enteroscopy in children with obscure gastrointestinal bleeding. A combined approach, file e3835324-12aa-15e8-e053-a505fe0a3de9
|
2
|
|
Mucosal healing in Crohn's disease: new insights, file e3835325-f652-15e8-e053-a505fe0a3de9
|
2
|
|
Phenotype and natural history of children with coexistent inflammatory bowel disease and celiac disease, file a9c4a981-4829-4811-a2f7-eb034b29ebe4
|
1
|
|
Natural history of anemia and efficacy and safety of oral iron therapy in children newly diagnosed with inflammatory bowel disease, file b26205a1-aab5-41fb-87aa-cdf8b0df4e4c
|
1
|
|
Usefulness of single-balloon enteroscopy in pediatric Crohn's disease, file e3835312-255c-15e8-e053-a505fe0a3de9
|
1
|
|
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation, file e3835313-df4e-15e8-e053-a505fe0a3de9
|
1
|
|
European Crohn's and Colitis Organisation topical review on transitional care in inflammatory bowel disease, file e3835319-e511-15e8-e053-a505fe0a3de9
|
1
|
|
Looking beyond mucosal healing: effect of biologic therapy on transmural healing in pediatric Crohn's disease, file e383531b-9802-15e8-e053-a505fe0a3de9
|
1
|
|
A promising medium-term follow-up of pediatric sclerosing cholangitis. Mild phenotype or early diagnosis, file e383531e-8849-15e8-e053-a505fe0a3de9
|
1
|
|
Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: efficacy of infliximab as a rescue therapy, file e3835320-4b20-15e8-e053-a505fe0a3de9
|
1
|
|
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis, file e3835320-8e37-15e8-e053-a505fe0a3de9
|
1
|
|
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease, file e3835322-914e-15e8-e053-a505fe0a3de9
|
1
|
|
Role of bile acid receptors in the gut-liver axis, file e3835323-fe30-15e8-e053-a505fe0a3de9
|
1
|
|
null, file e3835328-53c1-15e8-e053-a505fe0a3de9
|
1
|
|
null, file e3835328-bad1-15e8-e053-a505fe0a3de9
|
1
|
|
Is fecal calprotectin a useful marker for small bowel Crohn's disease?, file e383532c-c525-15e8-e053-a505fe0a3de9
|
1
|
|
Real-life use of biosimilars in pediatric inflammatory bowel disease: a nation-wide web survey on behalf of the SIGENP IBD working group, file e383532d-b62b-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
2.426 |